Related Experiment Video
Updated: Jan 7, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Rethinking thrombophilia testing in pediatric VTE: A decade of real-world evidence
Mahdi Asleh1, Hadeel Musa2, Shirly Ammar3
1Pediatric Hemato-oncology Department, Saban Pediatric Medical Center, Soroka University Medical Center, Beer Sheva, Israel; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Insights
Routine thrombophilia testing in children with venous thromboembolism (VTE) did not change anticoagulation duration or predict recurrence. Selective testing is recommended over routine screening after a first VTE event.
Area of Science:
- Pediatric Hematology
- Thrombosis Research
- Clinical Outcomes Analysis
Background:
- The clinical value of routine thrombophilia testing in pediatric venous thromboembolism (VTE) management remains controversial.
- This study aimed to assess the real-world impact of thrombophilia testing on treatment and patient outcomes.
Purpose of the Study:
- To evaluate if thrombophilia testing influences anticoagulation duration in pediatric VTE patients.
- To determine the association between thrombophilia status and VTE recurrence and thrombus resolution.
Main Methods:
- A 10-year retrospective cohort study included 67 pediatric patients diagnosed with VTE.
- Analysis focused on the relationship between thrombophilia status and anticoagulation duration, VTE recurrence rates, and imaging-confirmed thrombus resolution.
Main Results:
- A positive thrombophilia workup did not significantly alter anticoagulation duration compared to negative results.
- Thrombophilia status was not a significant predictor of VTE recurrence.
- Positive thrombophilia workup was associated with a higher rate of Residual Vein Obstruction (RVO), but RVO did not predict recurrence.
Conclusions:
- Thrombophilia testing in pediatric VTE patients did not impact treatment duration or recurrence prediction.
- Findings support current guidelines favoring selective, clinically guided thrombophilia testing over routine use after an initial pediatric VTE event.
Background:
The clinical utility of routine thrombophilia testing to guide management in pediatric venous thromboembolism (VTE) is debated. This study sought to evaluate the real-world impact of thrombophilia testing on anticoagulation duration and clinical outcomes.
Methods:
We conducted a 10-year retrospective cohort study of 67 pediatric patients with VTE. We analyzed the association between thrombophilia status and anticoagulation duration, VTE recurrence, and thrombus resolution on follow-up imaging.
Results:
The majority of VTE events (80.6 %) were provoked. A positive thrombophilia workup did not significantly alter the median anticoagulation duration compared to a negative workup (p = 0.582). A positive thrombophilia status was not a significant predictor of VTE recurrence in survival analysis (HR 2.22, p = 0.281). However, a positive workup was significantly associated with a higher rate of Residual Vein Obstruction (RVO) (73.3 % vs. 36.4 %, p = 0.045). This imaging finding did not, in turn, predict VTE recurrence (p = 0.388).
Conclusion:
Thrombophilia testing did not influence treatment duration or predict recurrence. Our findings provide real-world evidence supporting current guidelines that advocate for a selective, clinically driven approach to testing rather than its routine use after a first pediatric VTE.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

